Carboplatin-Taxol-Bevacizumab Regimen

Known as: Carbo-Taxol-Avastin Regimen, carboplatin-paclitaxel-bevacizumab regimen 
A chemoimmunotherapy regimen consisting of carboplatin, paclitaxel and bevacizumab used to treat advanced stage, non-small cell lung cancer which is… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
INTRODUCTION In the last years, a spectacular development of immunotherapeutic agents aimed at the PD-1/PD-L1 axis has taken… (More)
  • figure 2
  • table 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2017
2017
The ovary is an organ that can be the site of metastases for many cancers. In general, malignant ovarian tumors are primary… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2015
2015
A 65-year-old woman with a right breast tumor and right arm pain was seen in our hospital. She was diagnosed with scirrhous… (More)
Is this relevant?
2014
2014
2001^ Background: Factors that correlate the extent of clinical benefit with anti-VEGF therapy are poorly understood. Two phase 3… (More)
Is this relevant?
2011
2011
combined with other chemotherapy (CT) agents was demonstrated in AVADO and RIBBON-1. Subgroup analyses of all 3 trials suggest… (More)
Is this relevant?
Review
2009
Review
2009
OBJECTIVE To determine efficacy, toxicity, and survival in patients with recurrent epithelial ovarian cancer (EOC) receiving… (More)
Is this relevant?
Review
2007
Review
2007
Angiogenesis and its role in the growth and development of metastases has become a topic of increasing importance. In non-small… (More)
Is this relevant?
2001
2001
AIM: To determine the effect of radiosensitization with Taxol and multimodality treatments on the survival of advanced oral and… (More)
Is this relevant?